Liothyronine is a manufactured form of the thyroid hormone triiodothyronine (T3).[1] It is most commonly used to treat hypothyroidism and myxedema coma.[1] It can be taken by mouth or by injection into a vein.[1]
Side effects may occur from excessive doses.[1] This may include weight loss, fever, headache, anxiety, trouble sleeping, arrythmias, and heart failure.[1] Use in pregnancy and breastfeeding is generally safe.[2][1] Regular blood tests are recommended to verify the appropriateness of the dose being taken.[1]
Liothyronine was approved for medical use in 1956.[1] It is available as a generic medication.[2] In 2021, it was the 199th most commonly prescribed medication in the United States, with more than 2million prescriptions.[3][4]
^ abcdefgh"Liothyronine Sodium Monograph for Professionals". Drugs.com. Retrieved 27 February 2019.
^ abBritish National Formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 757. ISBN 9780857113382.
^"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
^"Liothyronine - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
Liothyronine is a manufactured form of the thyroid hormone triiodothyronine (T3). It is most commonly used to treat hypothyroidism and myxedema coma. It...
liothyronine. People with hypothyroidism who do not feel well despite optimal levothyroxine dosing may request adjunctive treatment with liothyronine...
the CMA’s decision on the pricing of liothyronine tablets and will be appealing. In addition, any liothyronine price increases were all pre-notified...
in different ratios (such as liotrix) and pure-T3 medications (INN: liothyronine). Levothyroxine Sodium is usually the first course of treatment tried...
either the thyroid hormone L-thyroxine given intravenously or by giving liothyronine via a nasogastric tube. It is essential to identify and treat the condition...
AE, Getka EJ, Shakir KM (December 2003). "Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized...
Harrison D (2015). "Iatrogenic thyrotoxicosis secondary to compounded liothyronine". The Canadian Journal of Hospital Pharmacy. 68 (1): 57–9. doi:10.4212/cjhp...